| Line item | 2025-12-31 FY | 2025-09-30 FY | 2025-06-30 FY | 2025-03-31 FY | 2024-12-31 FY | 2024-09-30 FY | 2024-06-30 FY | 2024-03-31 FY |
|---|---|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – | – | – |
| Operating Expenses | $88.63M | – | – | – | $182.59M | – | – | – |
| R&D | – | – | – | – | – | – | – | – |
| SG&A | – | – | – | – | – | – | – | – |
| Operating Income | – | – | – | – | – | – | – | – |
| Interest Expense | – | – | – | – | – | – | – | – |
| Tax Expense | – | – | – | – | – | – | – | – |
| Net Income | -$618.75M | $1.84B | $754.40M | -$1.99B | $2.59B | -$1.82B | -$695.32M | $3.95B |
| EPS (basic) | – | – | – | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – | – | – | – |